Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
DMN:FRA
Diamyd Medical AB
€0.062
-19.24%
(-0.015) 1D
Apr 24, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DMN...
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
162.09M
Avg. vol.
2.31K
Volume
0.00
52-wk high
€1.80
52-wk low
€0.06
No. of employees
41
News stories
From sources across the web
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products. The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
About Diamyd Medical AB
CEOUlf Hannelius
Employees41
Founded1984
Headquarters-
SectorBiotechnology
Websitediamyd.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
-
19.00K
245.00K
99.00K
Cost of goods sold
953.00K
718.00K
938.00K
786.00K
Cost of revenue
953.00K
718.00K
938.00K
786.00K
Research and development expenses
31.68M
30.48M
30.47M
45.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.89M
14.12M
16.82M
18.30M
Operating expense
47.17M
45.81M
48.14M
64.34M
Total operating expenses
48.12M
46.53M
49.08M
65.12M
Operating income
-48.12M
-46.51M
-48.84M
-65.02M
Other non operating income
-
-3.00K
1.00K
1.00K
EBT including unusual items
-43.88M
-44.86M
-48.84M
-62.88M
EBT excluding unusual items
-43.63M
-44.86M
-48.06M
-62.88M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-1.07M
-536.00K
-925.00K
-840.00K
Net income
-43.88M
-44.86M
-48.84M
-62.88M
Net profit margin
-
-236,126.32%
-19,936.33%
-63,513.13%
Earnings per share
-
-
-
-
Interest and investment income
5.32M
3.70M
833.00K
2.78M
Interest expense
-828.00K
-6.21M
-62.00K
-635.00K
Net interest expenses
4.49M
-2.51M
771.00K
2.14M
Depreciation and amortization charges
1.66M
1.76M
1.78M
1.78M
EBITDA
-46.46M
-44.87M
-47.06M
-63.24M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more